skip navigation

• Home
• Guidelines
  • Antiretroviral Treatment
    • Adult and Adolescent ARV Guidelines
    • Pediatric ARV Guidelines
  • Maternal-Child Transmission
    • Perinatal Guidelines
  • Management of HIV Complications
    • Adult and Adolescent OI Prevention and Treatment Guidelines
    • Pediatric OI Prevention and Treatment Guidelines
  • Care for Disaster Displaced HIV-Infected Patients
    • Guidelines on Care for HIV-Infected Residents Displaced from Disaster Areas
  • Preexposure Prophylaxis
    • Preexposure Prophylaxis (PrEP) Guidelines
  • Postexposure Prophylaxis
    • Occupational Postexposure Prophylaxis (PEP) Guidelines
    • Nonoccupational Postexposure Prophylaxis (nPEP) Guidelines
  • Prevention
    • HIV Counseling, Testing, and Referral Guidelines
    • Guidelines on Incorporating HIV Prevention into Medical Care

  Search the Guidelines

  Please Select a Guideline Adult and Adolescent Guidelines Pediatric Guidelines Perinatal Guidelines

  Search Guidelines
• Clinical Trials
  Clinical Trials Search Options

  Search by Keyword

  

  
  
  
  
  

  ---

  Search by Category

  Select a topic Cancer Coinfections Complications/Side Effects Opportunistic Infections Prevention Research Specific Populations Treatment Research Vaccine Research Trials by Age Trials by Study Type
  
  

  Search by Topics

  Select a subtopic

  
  
  Advanced Search

   

   

   

   

   

   

   

   

  • Download Education Materials
    • What is an HIV/AIDS Clinical Trial (PDF)
    • Preventive HIV Vaccines (PDF)
    • Therapeutic HIV Vaccines (PDF)
• Drugs
  • FDA-approved
    • Combination Drugs
    • Entry and Fusion Inhibitors
    • Integrase Inhibitors
    • Non-nucleoside Reverse Transcriptase Inhibitors
    • Nucleoside Reverse Transcriptase Inhibitors
    • Opportunistic Infections
    • Protease Inhibitors
  • Investigational
    • Entry and Fusion Inhibitors
    • Integrase Inhibitors
    • Non-nucleoside Reverse Transcriptase Inhibitors
    • Nucleoside Reverse Transcriptase Inhibitors

  Search HIV/AIDS Drugs

  

  Alphabetical Search

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  All Drugs
• HIV/AIDS Health Topics
  • HIV/AIDS-Related Guidelines
  • Staying Healthy with HIV
  • Specific Populations
  • Treatment Resources
  • HIV/AIDS-Related Conditions
  • Prevention Research
  • General Information
  • Clinical Research
  • For Health Care Providers
  • For Researchers

  Search HIV/AIDS Health Topics

  

  Alphabetical Search

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  All Topics
• Education Materials
  • Glossary
  • HIV and Its Treatment Fact Sheet (PDF)
  • Pregnancy Fact Sheet (PDF)
  • More Fact Sheets
  • HIV/AIDS Awareness Day Pages

  Search the Glossary

  (Other Education Materials not included)

  

  Alphabetical Glossary Search

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  All Glossary Terms
• Mobile Resources & Tools
  • Mobile Site
  • Apps
  • APIs
  • Widgets
  • Order Publications

Skip Navigation

Drug Name

Search Results

4 Results for Nucleoside Reverse Transcriptase Inhibitors, Investigational

BMS-986001

Other Name(s): festinavir, OBP-601, 4'-ethynyl-d4T, 4'-Ed4T

http://aidsinfo.nih.gov/drugs/515/bms-986001/0/patient/

Elvucitabine

Other Name(s): ACH-126443, L-F-D4C

http://aidsinfo.nih.gov/drugs/385/elvucitabine/0/patient/

GS-7340

Other Name(s): Prodrug of tenofovir

http://aidsinfo.nih.gov/drugs/514/gs-7340/0/patient/

Racivir

Other Name(s): (+)/(-)FTC, RCV

http://aidsinfo.nih.gov/drugs/386/racivir/0/patient/